BMO Capital Markets Increases Allstate (NYSE:ALL) Price Target to $214.00

Allstate (NYSE:ALL) had its price objective hoisted by BMO Capital Markets from $205.00 to $214.00 in a research report report published on Friday morning, Marketbeat.com reports. They currently have an outperform rating on the insurance provider’s stock.

ALL has been the topic of a number of other research reports. Evercore ISI increased their target price on Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a research note on Wednesday, October 9th. TD Cowen raised their price objective on Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a report on Tuesday, September 3rd. Barclays assumed coverage on Allstate in a research note on Wednesday, September 4th. They issued an “underweight” rating and a $175.00 target price for the company. Bank of America decreased their price target on shares of Allstate from $226.00 to $216.00 and set a “buy” rating on the stock in a research note on Thursday, October 10th. Finally, The Goldman Sachs Group upped their price objective on shares of Allstate from $199.00 to $204.00 and gave the company a “buy” rating in a research note on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $202.59.

Allstate Trading Down 0.0 %

Shares of ALL stock opened at $195.44 on Friday. The business’s fifty day moving average is $186.66 and its 200 day moving average is $173.80. Allstate has a 52-week low of $121.70 and a 52-week high of $198.79. The company has a market capitalization of $51.58 billion, a PE ratio of 43.14, a price-to-earnings-growth ratio of 1.74 and a beta of 0.48. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.36 and a current ratio of 0.36.

Allstate (NYSE:ALL) last announced its earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $1.28. The business had revenue of $15.71 billion during the quarter, compared to analyst estimates of $14.04 billion. Allstate had a net margin of 5.03% and a return on equity of 24.05%. Allstate’s revenue for the quarter was up 12.4% on a year-over-year basis. During the same period in the previous year, the business posted ($4.42) earnings per share. On average, equities research analysts anticipate that Allstate will post 15.19 EPS for the current fiscal year.

Insider Buying and Selling at Allstate

In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the transaction, the chief executive officer now owns 88,552 shares in the company, valued at approximately $15,880,915.68. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the sale, the chief executive officer now directly owns 88,552 shares in the company, valued at $15,880,915.68. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Toohey sold 16,682 shares of the stock in a transaction on Monday, August 19th. The stock was sold at an average price of $180.17, for a total value of $3,005,595.94. Following the completion of the transaction, the executive vice president now owns 4,873 shares of the company’s stock, valued at approximately $877,968.41. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 192,530 shares of company stock valued at $34,967,665. 1.80% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Allstate

Several hedge funds have recently bought and sold shares of the business. Rise Advisors LLC purchased a new position in shares of Allstate during the first quarter valued at approximately $26,000. Northwest Investment Counselors LLC bought a new position in Allstate during the 1st quarter valued at approximately $26,000. Versant Capital Management Inc raised its stake in Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after buying an additional 78 shares during the last quarter. Family Firm Inc. bought a new stake in Allstate in the second quarter worth $38,000. Finally, MCF Advisors LLC grew its stake in shares of Allstate by 33.9% in the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 84 shares during the last quarter. Institutional investors own 76.47% of the company’s stock.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.